Efficient Transfection of Large Plasmids Encoding HIV-1 into Human Cells—A High Potential Transfection System Based on a Peptide Mimicking Cationic Lipid
Authors:
Open Access
- 25 August 2020
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 12 (9) , 805
Abstract
One major disadvantage of nucleic acid delivery systems is the low transfection or transduction efficiency of large-sized plasmids into cells. In this communication, we demonstrate the efficient transfection of a 15.5 kb green fluorescent protein (GFP)-fused HIV-1 molecular clone with a nucleic acid delivery system prepared from the highly potent peptide-mimicking cationic lipid OH4 in a mixture with the phospholipid DOPE (co-lipid). For the transfection, liposomes were loaded using a large-sized plasmid (15.5 kb), which encodes a replication-competent HIV type 1 molecular clone that carries a Gag-internal green fluorescent protein (HIV-1 JR-FL Gag-iGFP). The particle size and charge of the generated nanocarriers with 15.5 kb were compared to those of a standardized 4.7 kb plasmid formulation. Stable, small-sized lipoplexes could be generated independently of the length of the used DNA. The transfer of fluorescently labeled pDNA-HIV1-Gag-iGFP in HEK293T cells was monitored using confocal laser scanning microscopy (cLSM). After efficient plasmid delivery, virus particles were detectable as budding structures on the plasma membrane. Moreover, we observed a randomized distribution of fluorescently labeled lipids over the plasma membrane. Obviously, a significant exchange of lipids between the drug delivery system and the cellular membranes occurs, which hints toward a fusion process. The mechanism of membrane fusion for the internalization of lipid-based drug delivery systems into cells is still a frequently discussed topic.Keywords
Funding Information
- Peter und Traudl Engelhorn Stiftung (stipendium)
This publication has 29 references indexed in Scilit:
- Gene Therapy ArrivesNature, 2019
- Colloidally Stable Small Unilamellar Stearyl Amine Lipoplexes for Effective BMP-9 Gene Delivery to Stem Cells for Osteogenic DifferentiationAAPS PharmSciTech, 2018
- Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivoNature Biotechnology, 2016
- Viral Vectors for Gene Therapy: Translational and Clinical OutlookAnnual Review of Biomedical Engineering, 2015
- $1-million price tag set for Glybera gene therapyNature Biotechnology, 2015
- Glybera's Second Act: The Curtain Rises on the High Cost of TherapyMolecular Therapy, 2015
- CRISPR-Cas systems for editing, regulating and targeting genomesNature Biotechnology, 2014
- Gene therapy and DNA delivery systemsInternational Journal of Pharmaceutics, 2014
- State-of-the-art gene-based therapies: the road aheadNature Reviews Genetics, 2011
- Genetic medicines: treatment strategies for hereditary disordersNature Reviews Genetics, 2006